Data search


search
Exact
Search

Results for MligTC455_54235

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_54235 6425 133.86 Mlig455_005204

Neo: -

Age: logFC(26M/2M)=0.258

Mlig455_005204 {REF} {Length: 1035} {TRANSSPLICED} {Pfam: Shadow of prion protein, neuroprotective [PF14999.8, score=20.7]} {RNA1509_1933} {RNA1310_32718} {RNA815_15584}

Cumulative graph for MligTC455_54235

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -0.323 7.189 0.50794 1.00000
RegionR2 -0.368 7.189 0.23545 0.60900
RegionR3 0.095 7.189 0.71541 1.00000
RegionR4 0.325 7.189 0.27267 0.57894
RegionR5 0.362 7.189 0.14201 0.38855
RegionR6 -0.134 7.189 0.61102 1.00000
RegionR7 0.121 7.189 0.66116 1.00000
RegionR8 -0.077 7.189 0.81212 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -1.05 7.189 0.13621 0.87134
RegenerationR2 0.216 7.189 0.48956 0.86753
RegenerationR3 0.455 7.189 0.15900 0.59099
RegenerationR4 0.173 7.189 0.60645 0.91579
RegenerationR5 0.233 7.189 0.46583 0.84041
RegenerationR6 0.228 7.189 0.49037 0.79916
RegenerationBL 0.685 7.189 0.01756 0.14164
RegenerationTP -0.089 7.189 0.78790 1.00000


Genes with expression patterns similar to MligTC455_54235

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_54235 6425 133.86 Mlig455_005204

Neo: -

Age: logFC(26M/2M)=0.258

6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_005204 {REF} {Length: 1035} {TRANSSPLICED} {Pfam: Shadow of prion protein, neuroprotective [PF14999.8, score=20.7]} {RNA1509_1933} {RNA1310_32718} {RNA815_15584}
2. MligTC455_46615 798 16.62 Mlig455_010462

Neo: -

Age: -

Region-enriched R4: 1.396/0.00876

DLST 1.684 - - - 0.961 - 0.723 Mlig455_010462 {REF} {Length: 3561} {Pfam: 2-oxoacid dehydrogenases acyltransferase (catalytic domain) [PF00198.25, score=253.1]; Biotin-requiring enzyme [PF00364.24, score=66.2]} {Human: ENSG00000119689, DLST, dihydrolipoamide S-succinyltransferase, [RH, Score=475, Expect=1e-165]} {Mouse: ENSMUSG00000004789, Dlst, dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), [RH, Score=471, Expect=5e-164]} {Dmel: FBgn0037891, CG5214, [RH, Score=363, Expect=1e-121]} {Celegans: WBGene00020950, dlst-1, DihydroLipoamide S-SuccinylTransferase, [RH, Score=471, Expect=4e-164]} {Smed: dd_Smed_v6_1456_0_1, dd_Smed_v6_1456_0_1, [RH, Score=460, Expect=2e-160]} {RNA1509_11693, RNA1509_19368, RNA1509_28903, RNA1509_42953} {RNA1310_127, RNA1509_11693, RNA1509_19368, RNA1509_28903, RNA1509_42953} {RNA1509_11693, RNA1509_19368, RNA1509_28903, RNA1509_42953, RNA815_3576}
3. MligTC455_19620 4056 84.5 Mlig455_058379

Neo: -

Age: -

GHITM 0.971 - - - 0.971 - - Mlig455_058379 {REF} {Length: 1356} {TRANSSPLICED} {Pfam: Inhibitor of apoptosis-promoting Bax1 [PF01027.22, score=152.9]} {Human: ENSG00000165678, GHITM, growth hormone inducible transmembrane protein, [RH, Score=247, Expect=1e-79]} {Mouse: ENSMUSG00000041028, Ghitm, growth hormone inducible transmembrane protein, [RH, Score=244, Expect=8e-79]} {Dmel: FBgn0030263, CG2076, [RH, Score=253, Expect=3e-82]} {Celegans: WBGene00019664, K11H12.8, [RH, Score=223, Expect=2e-70]} {Smed: dd_Smed_v6_754_0_1, dd_Smed_v6_754_0_1, [RH, Score=211, Expect=6e-66]} {RNA1509_3934, RNA1509_52748} {RNA1310_24357.2, RNA1509_3934, RNA1509_52748} {RNA1509_3934, RNA1509_52748, RNA815_10661}
4. MligTC455_36709 3794 79.04 Mlig455_059511

Neo: -

Age: Down-Up-Up

Region-enriched R4: 1.064/0.00002

TXN2 0.968 - - - 0.968 - - Mlig455_059511 {REF} {Length: 986} {TRANSSPLICED} {Pfam: Thioredoxin [PF00085.22, score=66.7]} {Human: ENSG00000100348, TXN2, thioredoxin 2, [RH, Score=102, Expect=4e-27]} {Mouse: ENSMUSG00000005354, Txn2, thioredoxin 2, [RH, Score=100, Expect=4e-27]} {Dmel: FBgn0035334, CG8993, [RH, Score=81.3, Expect=2e-19]} {Celegans: WBGene00007099, trx-2, Probable thioredoxin-2, [Score=79.7, Expect=4e-19]} {Smed: dd_Smed_v6_872_0_1, dd_Smed_v6_872_0_1, [RH, Score=89.7, Expect=3e-23]} {RNA1509_7447, RNA1509_8127} {RNA1310_36313.1, RNA1509_7447} {RNA1509_7447, RNA815_10101.2}
5. MligTC455_45741 179 3.73 Mlig455_057514

Neo: -

Age: -

0.967 - - - - 0.967 - Mlig455_057514 {REF} {Length: 1407} {RNA1509_42923} {RNA1310_32626, RNA1509_42923} {RNA1509_42923, RNA815_62782}
6. MligTC455_13953 56 1.16 Mlig455_069569

Neo: -

Age: -

0.96 - - - - - 0.960 Mlig455_069569 {REF} {Length: 925} {TRANSSPLICED} {Pfam: Ovarian carcinoma immunoreactive antigen (OCIA) [PF07051.13, score=48.1]} {Dmel: FBgn0034793, asrij, [RH, Score=48.9, Expect=8e-07]} {RNA1509_3611} {RNA1310_36785} {RNA815_24791}
7. MligTC455_27887 63 1.32 Mlig455_005896

Neo: -

Age: Down-Down-Up

0.96 - - - - 0.960 - Mlig455_005896 {REF} {Length: 2030} {TRANSSPLICED} {Pfam: AP-5 complex subunit sigma-1 [PF15001.8, score=43.7]} {RNA1509_48400} {RNA1310_26125} {RNA815_7192}
8. MligTC455_41720 3651 76.05 Mlig455_059515

Neo: -

Age: Down-Down-Up

Region-enriched R4: 1.422/0.00269

HPGDS 0.954 - - - 0.954 - - Mlig455_059515 {REF} {Length: 981} {TRANSSPLICED} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=49.1]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=40.7]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=25.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=82.0, Expect=7e-19]; ENSG00000084207, GSTP1, glutathione S-transferase pi 1, [Score=79.7, Expect=7e-18]} {Mouse: ENSMUSG00000097830, Gstp1, glutathione S-transferase, pi 1, [Score=80.9, Expect=2e-18]; ENSMUSG00000060803, Gstp1, glutathione S-transferase, pi 1, [Score=80.9, Expect=2e-18]} {Dmel: FBgn0010226, GstS1, Glutathione S transferase S1, [Score=70.5, Expect=1e-14]} {Celegans: WBGene00001789, gst-41, Glutathione S-Transferase, [Score=89.4, Expect=5e-22]} {Smed: dd_Smed_v6_816_0_1, dd_Smed_v6_816_0_1, [Score=68.2, Expect=3e-14]} {RNA1509_9144, RNA1509_9822} {RNA1310_35676, RNA1509_9144, RNA1509_9822} {RNA1509_9144, RNA1509_9822, RNA815_16772.1}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA